A Case-Control Study on Effect of Rotavirus Monovalent G9P[11] Vaccination on the Severity of Diarrhoea in Children Aged 2-24 Months in Indonesia

Fransiskus Koda; Andi  Zulkifli; Ida  Leida Maria; A Ummu  Salmah; Anwar  Mallongi

doi:10.55489/njcm.150820244167

Authors

Fransiskus Koda Hasanuddin University, Makassar, Indonesia
Andi Zulkifli Hasanuddin University, Makassar, Indonesia
Ida Leida Maria Hasanuddin University, Makassar, Indonesia
A Ummu Salmah Hasanuddin University, Makassar, Indonesia
Anwar Mallongi Hasanuddin University, Makassar, Indonesia

DOI:

https://doi.org/10.55489/njcm.150820244167

Keywords:

Children, Vaccine, Rotavirus, Severe Diarrhea

Abstract

Background: In Indonesia, rotavirus monovalent G9P[11] vaccine is the first rotavirus vaccine implemented through a government program and has never been evaluated. Makassar City is one of the 21 cities targeted for the introduction of rotavirus immunization in Indonesia. Aims/Objectives: To determine the association between rotavirus vaccination and the severity of diarrhoea in children aged 2-24 months.

Methodology: Facility-based Case-Control Study design was conducted at Daya and Paramount hospital in Makassar City in January-February 2024. A total of 180 respondents participated (90 cases and 90 controls). The sampling method used was non-probability sampling, specifically the consecutive sampling technique. Data were analysed using the logistic regression test in Stata version 14.

Results: Rotavirus vaccine status AOR = 4.25 (CI95% 1.82-9.90); P = 0.001. Not receiving the vaccine compared to receiving a partial dose of the vaccine COR = 4.03 (CI95% 1.79-9.16); P = 0.0002. Not receiving the vaccine compared to children receiving the full dose of the vaccine COR = 12.70 (CI95% 4.87-34.12); P = 0.0000. Duration of vaccine administration COR = 4.32 (CI95% 1.66-11.23); P = 0.0006.

Conclusions: The rotavirus vaccine status was significantly associated with the severity diarrhoea in children aged 2-24 months.

References

Diarrhoea. Available at: https://www.who.int/health-topics/diarrhoea#tab=tab_1. Accessed April, 12th, 2024.

Centers for Disease Control and Prevention. Incidence, Etiology, and Healthcare Utilization for Acute Gastroenteritis in the Community, United States. 2022. Emerg. Infect. Dis; Vol. 28, no. 11. Page no. 2234-2242. Doi: https://doi.org/10.3201/eid2811.220247 PMid:36285882 PMCid:PMC9622243

A. Lo Vecchio, M. L. Conelli, and A. Guarino. Infections and Chronic Diarrhea in Children. 2021. Pediatr. Infect. Dis. J; Vol. 40, no. 7: Page no. E255-E258. Doi: https://doi.org/10.1097/INF.0000000000003182 PMid:34097662

Child mortality (under 5 years). Available at: https://www.who.int/news-room/fact-sheets/detail/levels-and-trends-in-child-under-5-mortality-in-2020. Accessed April 14th, 2024

Diarrhoea remains a leading killer of young children, despite the availability of a simple treatment solution. Available at: https://data.unicef.org/topic/child-health/diarrhoeal-disease/#:~:text=Diarrhoea is a leading killer of children%2C. Accessed April 14th, 2024

World Health Organization. Summary of the WHO position paper on Rotavirus vaccines. WHO. 2021. pp. 1-14.

PH Dennehy. Rotavirus vaccines: An overview. Clin. Microbiology. Rev. 2008; Vol. 21 no. 1: Page no. 198-208. Doi: https://doi.org/10.1128/CMR.00029-07 PMid:18202442 PMCid:PMC2223838

T Varghese, G Kang, AD Steele. Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality. Vaccines. 2022; Vol. 10, no. 3: Page no. 1-15. Doi: https://doi.org/10.3390/vaccines10030346 PMid:35334978 PMCid:PMC8948967

Dinkes Provinsi Sulawesi Selatan. Data Cakupan Imunisasi Rotavirus Tahun 2022 (Data of Rotavirus Immunization Coverage in 2022). Ministry of Health Government of Indonesia. 2022.

NP Nair et al. Rotavirus vaccine impact assessment surveillance in India: Protocol and methods. BMJ Open. 2019; Vol. 9, no. 4. Doi: https://doi.org/10.1136/bmjopen-2018-024840 PMid:31028037 PMCid:PMC6502045

Rotavirus. Available at: https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-rotavirus. Accessed April 14th, 2024

AA Mir BA, Fomda, N Bali, M Bhat. Burden of Rotavirus Diarrhoea among Children Less than Five Years of Age Attending a Tertiary Care Institute with Acute Gastroenteritis: A Cross-sectional Study. J. Clin. Diagnostic Res. 2023; Vol. 17. no.12. Doi: https://doi.org/10.7860/JCDR/2023/61667.17901

D. Gbebangi-Manzemu et al., "Clinical profile of children under 5 years of age with rotavirus diarrhoea in a hospital setting in Kisangani, DRC, after the introduction of the rotavirus vaccine, a cross-sectional study. BMC Pediatr. 2023; Vol. 23, no. 1: Page no.1-9. Doi: https://doi.org/10.1186/s12887-023-04022-0 PMid:37095482 PMCid:PMC10123467

PG Daniel C. Payne1, Julie A Boom, Mary Allen Staat, Kathryn M, Edwards et al. Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009-2011. Physiol. Behav. 2017 Vol. 176, no. 3: Page no. 139-148, 2017. Doi: https://doi.org/10.1016/j.physbeh.2017.03.040 PMid:28363838 PMCid:PMC5510739

S Pérez-Vilar, J Díez-Domingo, M López-Lacort, S Martínez-Úbeda, MA Martinez-Beneito. Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study. BMC Infect. Dis. 2015; Vol. 15, no. 1: Page no. 1-9. Doi: https://doi.org/10.1186/s12879-015-0811-5 PMid:25872565 PMCid:PMC4351827

N Bhandari et al. Efficacy of a Monovalent Human-Bovine (116E) Rotavirus Vaccine in Indian Infants: A Randomised Double-Blind Placebo Controlled Trial. HHS Public Access. 2015; Vol. 383, no. 9935: Page no 2136-2143. Doi: https://doi.org/10.1016/S0140-6736(13)62630-6 PMid:24629994

S Shine, S Muhamud, S Adanew, A Demelash, M Abate. Prevalence and associated factors of diarrhea among under-five children in Debre Berhan town, Ethiopia 2018: A cross-sectional study. BMC Infect. Dis. 2020; Vol. 20, no. 1: Page no. 1-6. Doi: https://doi.org/10.1186/s12879-020-4905-3 PMid:32093615 PMCid:PMC7041267

G Shumetie, M Gedefaw, A Kebede, T Derso, Exclusive breastfeeding and rotavirus vaccination are associated with decreased diarrheal morbidity among under-five children in Bahir Dar, northwest Ethiopia Fred Paccaud. Public Health Rev. 2018; Vol. 39, no. 1: Page no 1-10. Doi: https://doi.org/10.1186/s40985-018-0107-6 PMid:30410814 PMCid:PMC6211495

D Mahamba et al. Prevalence and Factors Associated with Rotavirus Infection among Vaccinated Children Hospitalized for Acute Diarrhea in Mwanza City, Tanzania: A Cross-Sectional Study. Open J. Pediatr. 2020; Vol. 10, no. 03; Page no. 392-403, 2020. Doi: https://doi.org/10.4236/ojped.2020.103040

U Eraliev et al. Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia. Hum. Vaccines Immunother. 2021; Vol. 17, no. 2; Page no. 503-509. Doi: https://doi.org/10.1080/21645515.2020.1776034 PMid:32755429 PMCid:PMC7899686

R Black et al. Drivers of the reduction in childhood diarrhea mortality 1980-2015 and interventions to eliminate preventable diarrhea deaths by 2030. J. Glob. Health. 2-19; Vol. 9 no. 2: Page. 1-9. Doi: https://doi.org/10.7189/jogh.09.020801 PMid:31673345 PMCid:PMC6815873

AL Lopez et al. Effectiveness of monovalent rotavirus vaccine in the Philippines. Sci. Rep. 2018; Vol. 8, no. 1. Doi: https://doi.org/10.1038/s41598-018-32595-9 PMid:30250267 PMCid:PMC6155259

JL Walker et al. Effectiveness of oral rotavirus vaccination in England against rotavirus-confirmed and all-cause acute gastroenteritis. Vaccine X. 2019; Vol. 1. Doi: https://doi.org/10.1016/j.jvacx.2019.100005 PMid:31384727 PMCid:PMC6668223

K Araki et al. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children. Vaccine. 2018; Vol. 36, no. 34: Page no. 5187-5193. Doi: https://doi.org/10.1016/j.vaccine.2018.07.007 PMid:30037664

C Fu et al. Rotavirus Gastroenteritis Infection among Children Vaccinated and Unvaccinated with Rotavirus Vaccine in Southern China: A Population-Based Assessment. JAMA Netw. Open. 2018; Vol. 1, no. 4. Doi: https://doi.org/10.1001/jamanetworkopen.2018.1382 PMid:30646128 PMCid:PMC6324266

S Khagayi et al. Effectiveness of monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in kenyan children. Clin. Infect. Dis. 2020; Vol. 70, no. 11: Page no. 2298-2305. Doi: https://doi.org/10.1093/cid/ciz664 PMid:31326980 PMCid:PMC7245145

BF Middleton et al. Retrospective case-control study of 2017 g2p[4] rotavirus epidemic in rural and remote Australia. Pathogens. 2020; Vol. 9, no. 10: Page no. 1-12. Doi: https://doi.org/10.3390/pathogens9100790 PMid:32993048 PMCid:PMC7601783

A Skansberg, M Sauer, M Tan, M Santosham, MC Jennings. Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1. Hum. Vaccines Immunother. 2021; Vol. 17, no. 4: Page no. 1223-1234. Doi: https://doi.org/10.1080/21645515.2020.1804245 PMid:33121329 PMCid:PMC8018392

AL Lopez et al. Efektivitas vaksin rotavirus monovalen di Filipina. Sci. Rep. 2018; Vol. 8, no. 1.

KM Kazimbaya, S Bosomprah, M Simuyandi, CC Chisenga, R Chilengi, S Munsaka. Efficacy and Effectiveness of Rotavirus Vaccine on Incidence of Diarrhoea among Children: A Meta-analysis. Pediatr. Infect. Dis. 2018; Vol. 03, no. 01. Doi: https://doi.org/10.21767/2573-0282.100060

A Clark et al. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. Lancet Infect. Dis. 2019; Vol. 19, no. 7: Page no. 717-727. Doi: https://doi.org/10.1016/S1473-3099(19)30126-4 PMid:31178289

H Bergman et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst. Rev. 2021; Vol. 2021, no. 11. Doi: https://doi.org/10.1002/14651858.CD008521.pub6 PMid:34788488 PMCid:PMC8597890

L Watson, T Shibata S, Ansariadi, A Maidin, I Nikitin, J Wilson. Understanding modifiable risk factors associated with childhood diarrhea in an eastern Indonesian urban setting, Int. J. Heal. Promot. Educ. 2015; Vol. 53, no. 1: Page no. 42-54. Doi: https://doi.org/10.1080/14635240.2014.951491

Merck Sharp & Dohme Indonesia. Efektifitas Vaksin Rotavirus Pentavalen dalam mencegah infeksi Rotavirus (Effectiveness of Pentavalent Rotavirus Vaccine in preventing Rotavirus infection). Jakarta-Indonesia. 2022.

B Cheuvart et al. Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: Analysis of clinical trials of human rotavirus vaccine. Hum. Vaccines Immunother. 2014; Vol. 10, no. 2: Page no. 505-511. Doi: https://doi.org/10.4161/hv.27097 PMid:24240068 PMCid:PMC4185910

M Hasso-Agopsowicz et al. Global review of the age distribution of rotavirus disease in children aged <5 years before the introduction of rotavirus vaccination. Clin. Infect. Dis.2019; Vol. 69, no. 6: Page no. 1071-1078.

P Anwari et al. Rotavirus is the leading cause of hospitalizations for severe acute gastroenteritis among Afghan children <5 years old. Vaccine. 2018; Vol. 36, no. 51: Page no. 7765-7768. Doi: https://doi.org/10.1016/j.vaccine.2017.06.072 PMid:29510917

BN Tagbo et al. Rotavirus diarrhoea hospitalizations among children under 5 years of age in Nigeria, 2011-2016. Vaccine. 2018; Vol. 36, no. 51: Page no. 7759-7764. Doi: https://doi.org/10.1016/j.vaccine.2018.03.084 PMid:29802002

N Angkeabos et al. Pediatric hospitalizations attributable to rotavirus gastroenteritis among Cambodian children: Seven years of active surveillance, 2010-2016. Vaccine. 2018; Vol. 36, no. 51: Page no. 7856-7861. Doi: https://doi.org/10.1016/j.vaccine.2018.03.032 PMid:29588120

S. Kaggwa Lwanga and Stanley Lemeshow, Sample Size Determination in Health Studies: A Practical Manual. University of Michigan: World Health Organization. 1991